by TractManager | Oct 18, 2017 | Emerging Technology Report
The remedē system is a fully implanted neurostimulator intended for treatment of moderate-to-severe central sleep apnea in adults. The remedē system delivers unilateral transvenous phrenic nerve stimulation to cause diaphragmatic contraction that mimics a normal...
by TractManager | Oct 17, 2017 | Health Technology Assessment
Health Problem: Patients undergoing percutaneous coronary intervention (PCI) may be considered high risk based on a variety of factors, including advanced age, comorbidities, and lesion-specific characteristics. Patients undergoing high-risk PCI (HRPCI) may require...
by TractManager | Oct 17, 2017 | Precision Therapy Assessment
Rationale: The nonstructural proteins (NS) 3, 4A, and 5A (NS3, NS4A, and NS5A) are key enzymes in hepatitis C virus (HCV) RNA replication. Drugs targeting these enzymes are expected to inhibit HCV replication, thus lowering viral loads.Technology Description: Zepatier...
by TractManager | Oct 17, 2017 | Health Technology Assessment
Health Problem: Varicose veins, also known as varicosities, are a common manifestation of chronic venous insufficiency (CVI), a category of chronic venous disease (CVD). Varicose veins are enlarged and tortuous vessels (≥ 3 millimeters [mm] in diameter) that develop...
by TractManager | Oct 10, 2017 | Emerging Technology Report
The Impella RP system is a minimally invasive, miniaturized percutaneous circulatory support system for the right ventricle. The intent of the therapy with the Impella RP System is to provide a percutaneous circulatory support system to restore normal right heart...
Recent Comments